ASHLEY MCBRIDE: Open Payments
NPI 1477991024 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,664 in 82 payments from 32 companies in 2025. Trend: 2023 $1,662 · 2024 $1,789 · 2025 $1,664
Food & beverage: $1,664
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $299 |
| Novartis Pharmaceuticals Corporation | 9 | $215 |
| E.R. Squibb & Sons, L.L.C. | 6 | $114 |
| PFIZER INC. | 5 | $90 |
| BeOne Medicines USA, Inc. | 5 | $90 |
| Incyte Corporation | 4 | $83 |
| Daiichi Sankyo Inc. | 4 | $82 |
| Blueprint Medicines Corporation | 3 | $77 |
| Celgene Corporation | 2 | $47 |
| ARRAY BIOPHARMA INC | 3 | $46 |
Products named: IMFINZI, OPDIVO, Fabhalta, JAKAFI, LYNPARZA, AYVAKIT, BRUKINSA, Enhertu.
Industry payments across AL — which companies pay providers there.
